Establishment of head and neck squamous cell carcinoma mouse models for cetuximab resistance and sensitivity
Source
Cancer drug resistance - ISSN 2578-532X-6:4 (2023) p. 709-728
The prognostic impact of the immune signature in head and neck squamous cell carcinoma
Source
Frontiers in immunology - ISSN 1664-3224-13 (2022) p. 1-18
Combined targeting of the epidermal growth factor receptor and the innate immune system : a novel therapeutic approach for the treatment of head and neck cancer
Source
Antwerpen, Universiteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2022,225 p.
Recent insights in the PI3K/Akt pathway as a promising therapeutic target in combination with EGFR-targeting agents to treat head and neck squamous cell carcinoma
Source
Medicinal research reviews - ISSN 0198-6325-42:1 (2022) p. 112-155
The right partner in crime : unlocking the potential of the anti-EGFR antibody Cetuximab via combination with natural killer cell chartering immunotherapeutic strategies
Source
Frontiers in immunology - ISSN 1664-3224-12 (2021) p.